ViiV Healthcare Company et al v. Cipla Limited et al
| ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd. and ViiV Healthcare Company |
| Cipla Limited and Cipla USA, Inc. |
| 1:2020cv00977 |
| July 22, 2020 |
| US District Court for the District of Delaware |
| Mitchell S Goldberg |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 16, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pro Hac Vice Attorney Daniel O'Boyle for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG (myr) |
| Pro Hac Vice Attorney Caitlin Hogan for Shionogi & Co., Ltd., for ViiV Healthcare Company,for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG (myr) |
| Pro Hac Vice Attorney Lisa B. Pensabene for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG (myr) |
| Pro Hac Vice Attorney Carolyn Wall for Shionogi & Co., Ltd., for ViiV Healthcare Company, for ViiV Healthcare UK (No. 3) Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG (myr) |
Filing 11
ORDER granting (15) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:19-cv-02085-MSG; granting (17) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:20-cv-00293-MSG; granting (10) MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan in case 1:20-cv-00977-MSG. Signed by Judge Mitchell S. Goldberg on 9/14/2020. Associated Cases: 1:19-cv-02085-MSG, 1:20-cv-00293-MSG, 1:20-cv-00977-MSG(nmg)
|
| Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan - filed by Shionogi & Co., Ltd., ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (Attachments: #1 Certifications for Lisa B. Pensabene, Daniel OBoyle, Carolyn Wall, and Caitlin Hogan)(Silver, Daniel) |
| Case Assigned to Judge Mitchell S. Goldberg of the United States District Court for the Eastern District of Pennsylvania (due to related cases). Please include the initials of the Judge (MSG) after the case number on all documents filed. (rjb) |
| Filing 9 WAIVER OF SERVICE returned executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.: For Cipla Limited waiver sent on 7/23/2020, answer due 9/21/2020. (Silver, Daniel) |
| Filing 8 WAIVER OF SERVICE returned executed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.: For Cipla USA, Inc. waiver sent on 7/23/2020, answer due 9/21/2020. (Silver, Daniel) |
| Filing 7 Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Shionogi & Co., Ltd. (nmg) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc., Corporate Parent GlaxoSmithKline PLC, Corporate Parent Shionogi Limited, Corporate Parent Shionogi & Co., Ltd. for ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited. (nmg) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,242,986; 10,426,780. (nmg) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 6/10/2020. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 12/10/2022. (nmg) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3078891.) - filed by ViiV Healthcare Company, ViiV Healthcare UK (No. 3) Limited, Shionogi & Co., Ltd.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(nmg) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
